标题:Synthesis, characterization, and anticancer activities evaluation of compounds derived from 3,4-dihydropyrimidin-2(1H)-one
作者:Liu Y.; Liu J.; Zhang R.; Guo Y.; Wang H.; Meng Q.; Sun Y.; Liu Z.
作者机构:[Liu, Y] School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative In 更多
通讯作者:Liu, Z(lzl_0_0@126.com)
通讯作者地址:[Liu, Z] School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative In 更多
来源:Molecules
出版年:2019
DOI:10.3390/molecules24050891
关键词:3,4-dihydropyrimidin-2(1H)-ones; Anticancer activities; In vivo experiments; N 1 -alkylation; Structure-activity relationship
摘要:3,4-dihydropyrimidin-2(1H)-one compounds (DHPMs) possess extensive biological activities and are mainly prepared via Biginelli reaction and N-alkylation. In the present study, selective alkylation of N 1 was investigated by using tetrabutylammonium hydroxide. In vitro cytotoxicity study on all synthesized compounds demonstrated that introduction of the aryl chain in the R 3 as well as the low electron-donating group in the R 1 of DHPMs contributed to the anti-proliferative potency. A larger value of the partition coefficient (Log P) and suitable polar surface area (PSA) values were both found to be important in order to maintain the antitumor activity. The results from in vivo study indicated the great potential of compound 3d to serve as a lead compound for novel anti-tumor drugs to treat glioma. Pharmacophore study regarding the structure-activity relations of DHPMs were also conducted. Our results here could provide a guide for the design of novel bioactive 3,4-dihydropyrimidin-2(1H)-one compounds. © 2019 by the authors.
收录类别:SCOPUS
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062397120&doi=10.3390%2fmolecules24050891&partnerID=40&md5=9a6ce39f79afbec3814f133a089d9b55
TOP